Association of left ventricular diastolic dysfunction with elevated NT-pro-BNP in general intensive care unit patients with preserved ejection fraction: A complementary role of tissue doppler imaging parameters and nt-pro-bnp levels for adverse outcome

Shock

Volumn 33, Issue 2, 2010, Pages 141-148

  Ikonomidis, Ignatios ^a   Nikolaou, Maria ^a   Dimopoulou, Ioanna ^b   Paraskevaidis, Ioannis ^a   Lekakis, John ^a   Mavrou, Irini ^b   Tzanela, Marinella ^c   Kopterides, Petros ^b   Tsangaris, Iraklis ^b   Armaganidis, Apostolos ^b   Kremastinos, Dimitrios T H ^a  

^a Department of Cardiology ^*  (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c EVANGELISMOS HOSPITAL   (Greece)

Author keywords

Diastolic dysfunction; Intensive care unit; Natriuretic peptides; NTYpro BNP; Prognosis; Tissue Doppler imaging

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; CREATININE; LACTIC ACID; TROPONIN;

ADULT; AGE DISTRIBUTION; AGED; AREA UNDER THE CURVE; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ASSESSMENT; CRITICALLY ILL PATIENT; DIASTOLIC DYSFUNCTION; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; MORTALITY; MULTIVARIATE ANALYSIS; OXYGEN BLOOD LEVEL; PREDICTION; PROSPECTIVE STUDY; SEPSIS; SYSTOLIC DYSFUNCTION; TISSUE DOPPLER IMAGING; VELOCITY;

ECHOCARDIOGRAPHY, DOPPLER; HUMANS; INTENSIVE CARE UNITS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 77649151317     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181ad31f8     Document Type: Article

References (35)

1. de Rooij SE, Abu-Hanna A, Levi M, de Jonge E: Factors that predict outcome of intensive care treatment in very elderly patients: a review. Crit Care 9:307-314, 2005.
2. de Lemos JA, McGuire DK: Drazner MHB-type natriuretic peptide in cardiovascular disease. Lancet 362:316-322, 2003.
3. Kotanidou A, Karsaliakos P, Tzanela M, Mavrou I, Kopterides P, Papadomichelakis E, Theodorakopoulou M, Botoula E, Tsangaris I, Lignos M, et al.: Prognostic importance of increased plasma amino-terminal proYbrain natriuretic peptide levels in a large mixed intensive care unit population. Shock 31:342-347, 2009.
4. Januzzi JL, Morss A, Tung R, Pino R, Fifer MA, Thompson BT, Lee-Lewandrowski E: Natriuretic peptide testing for the evaluation of critically ill patients with shock in the intensive care unit: a prospective cohort study. Crit Care 10:37-43, 2006.
5. Varpula M, Pulkki K, Karlsson S, Ruokonen E, Pettilä V: Predictive value of N-terminal proYbrain natriuretic peptide in severe sepsis and septic shock. Crit Care Med 35:1277-1283, 2007.
6. Januzzi JL, van Kimmenade R, Lainchbury J, Bayes-Genis A, Ordonez-Llanos J, Santalo-Bel M, Pinto YM, Richards M: NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of patients: the International Collaborative of NT-proBNP Study. Eur Heart J 27:330-337, 2006.
7. Shah KB, Nolan MM, Rao K, Wang DJ, Christenson RH, Shanholtz CB, Mehra MR, Gottlieb SS: The characteristics and prognostic importance of NT-ProBNP concentrations in critically ill patients. Am J Med 120:1071-1077, 2007.
8. Meyer B, Huelsmann M, Wexberg P, Delle Karth G, Berger R, Moertl D, Szekeres T, Pacher R, Heinz G: N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients. Crit Care Med 35:2268-2273, 2007.
9. Paulus W, Tschpe C, Sanderson J, Rusconi C, Flachskampf F, Rademakers F, Marino P, Smiseth OA, De Keulenaer G, Leite-Moreira AF, et al.: How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 28:2539-2550, 2007. (Pubitemid 47614269)
10. Ma KK, Ogawa T, de Bold AJ: Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by proin-flammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase. J Mol Cell Cardiol 36:505-513, 2004.
11. Fried I, Bar-Oz B, Algur N, Fried E, Gavri S, Yatsiv I, MDf, Perles Z, Rein AJJT, Zonis Z, Bass R, et al.: Comparison of N-terminal pro-B-type natriuretic peptide levels in critically ill children with sepsis versus acute left ventricular dysfunction. Pediatrics 118:e1165-e1168, 2006.
12. Hopkins WE, Chen Z, Fukagawa NK, Hall C, Knot HJ, LeWinter MM: Increased atrial and brain natriuretic peptides in adults with cyanotic congenital heart disease: enhanced understanding of the relationship between hypoxia and natriuretic peptide secretion. Circulation 109:2872-2877, 2004.
13. Rudiger A, Gasser S, Fischler M, Hornemann T, Von Eckardstein A, Maggiorini M: Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure. Crit Care Med 34:2140-2144, 2006.
14. Mills RM, LeJemtel TH, Horton DP, Liang C, Lang R, Silver MA, Lui C, Chatterjee K: Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial: Natrecor Study Group. J Am Coll Cardiol 34:155-162, 1999.
15. Sackner-Bernstein JD, Skopicki HA, Aaronson KD: Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 111:1487-1491, 2005.
16. Sackner-Bernstein JD, Kowalski M, Fox M: Short-term risk of death after treatment with nesiritide for decompensated heart failure. A pooled analysis of randomized controlled trials. JAMA 293:1900-1905, 2005.
17. Zakynthinos E, Kiropoulos T, Gourgoulianis K, Filipatos G: Diagnostic and prognostic impact of brain natriuretic peptide in cardiac and noncardiac diseases. Heart Lung 37:275-285, 2008.
18. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quiñones MA: Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 30: 1527-1533,1997.
19. Nikitin NP, Witte KK, Thackray SD, de Silva R, Clark AL, Cleland JG: Longitudinal ventricular function: normal values of atrioventricular annular and myocardial velocities measured with quantitative two-dimensional color Doppler tissue imaging. J Am Soc Echocardiogr 16:906-921, 2003.
20. Yip G, Wang M, Zhang Y, Fung JW, Ho PY, Sanderson JE: Left ventricular long axis function in diastolic heart failure is reduced in both diastole and systole: time for a redefinition? Heart 87:121-125, 2002.
21. Pavlopoulos H, Grapsa J, Stefanadi E, Kamperidis V, Philippou E, Dawson D, Nihoyannopoulos P: The evolution of diastolic dysfunction in the hypertensive disease. Eur J Echocardiogr 9:772-778, 2008.
22. Mottram PM, Marwick TH: Assessment of diastolic function: what the general cardiologist needs to know. Heart 91:681-695, 2005.
23. Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh JK, Redfield MM, Tajik AJ: Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation 102:1788-1794, 2000.
24. Motram P, Haluska B, Marwick T: Response of B-type natriuretic peptide to exercise in hypertensive patients with suspected diastolic heart failure: correlation with cardiac function, hemodynamics, and workload. Am Heart J 148:365-370, 2004.
25. Y u CM, Sanderson JE, Marwick TH, Oh JK: Tissue Doppler imaging a new prognosticator for cardiovascular diseases. J Am Coll Cardiol 49:1903-1914, 2007.
26. Charpentier J, Luyt CE, Fulla Y, Vinsonneau C, Cariou A, Grabar S, Dhainaut JF, Mira JP, Chiche JD: Brain natriuretic peptide: a marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med 32:660-665, 2004.
27. Levy M, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G: SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med 31:1250-1256, 2001. (Pubitemid 36444440)
28. Ikonomidis I, Athanassopoulos G, Stamatelopoulos K, Lekakis J, Revela I, Venetsanou K, Marinou M, Monaco C, Cokkinos DV, Nihoyannopoulos P: Additive prognostic value of interleukin-6 at peak phase of dobutamine stress echocardiography in patients with coronary artery disease. A 6-year follow-up study. Am Heart J 156:269-276, 2008.
29. Combes A, Arnoult F, Trouillet JL: Tissue Doppler imaging estimation of pulmonary artery occlusion pressure in ICU patients. Intensive Care Med 30:75-81, 2004.
30. Lenzen MJ, Scholte OP, Reimer WJM, Boersma E, Vantrimpont PJMJ, Follath F, Swedberg K, Cleland J, Komajda M: Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey. Eur Heart J 25:1214-1220, 2004.
31. Teplinsky K, O'Toole M, Olman M,Walley KR, Wood LD: Effect of lactic acidosis on canine hemodynamics and left ventricular function. Am J Physiol 258:H1193-H1199, 1990.
32. Ikonomidis I, Lekakis JP, Nikolaou M, Paraskevaidis I, Andreadou I, Kaplanoglou T, Katsimbri P, Skarantavos G, Soucacos PN, Kremastinos DT: Inhibition of interleukin-1 by anakinra improves vascular and left ventricular function in patients with rheumatoid arthritis. Circulation 117:2662-2669, 2008.
33. Court O, Kumar A, Parrillo JE, Kumar A: Clinical review: myocardial depression in sepsis and septic shock. Crit Care 6:500-508, 2002.
34. Forfia PR, Watkins SP, Rame JE, Stewart KJ, Shapiro EP: Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit. J Am Coll Cardiol 45:1667-1671, 2005.
35. Wolff B, Haase D, Lazarus P, Machill K, Graf B, Lestin HG, Werner D: Severe septic inflammation as a strong stimulus of myocardial NT-pro brain natriuretic peptide release. Int J Cardiol 122:131-136, 2007.